Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lafyatis

Showing results (181-190 of 257) with videos related to

Pageof 26
Sort By:
Immunity|September 1, 2019
Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor ClearanceDayana B Rivadeneira, Kristin DePeaux, Yiyang Wang, et al.
Plos Computational Biology|December 22, 2022
An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumorsXueer Chen, Lujia Chen, Cornelius H L Kürten, et al.
ERJ Open Research|January 15, 2025
Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertensionAnna Kirillova, Meena Sethuraman, Xishuang Dong, et al.
Arthritis Care & Research|August 7, 2025
LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung DiseaseCristina M Padilla, Robert Lafyatis, Kevin F Gibson, et al.
The European Respiratory Journal|June 22, 2019
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosisChristina Morse, Tracy Tabib, John Sembrat, et al.
Arthritis Research & Therapy|January 24, 2016
Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosisMichael E Johnson, Andrew V Grassetti, Jaclyn N Taroni, et al.
Human Immunology|November 27, 2008
The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patientsTimothy R D J Radstake, Madelon C Vonk, Marieke Dekkers, et al.
Nature Communications|June 4, 2016
Tenascin-C drives persistence of organ fibrosisSwati Bhattacharyya, Wenxia Wang, Luisa Morales-Nebreda, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysisSébastien Sanges, Lisa Rice, Ly Tu, et al.
Journal of Scleroderma and Related Disorders|January 10, 2022
A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic SclerosisKristi Kong, Diane Koontz, Christina Morse, et al.
Pageof 26

Showing results (181-190 of 257) with videos related to

Sort By:
Pageof 26
Immunity|September 1, 2019
Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor ClearanceDayana B Rivadeneira, Kristin DePeaux, Yiyang Wang, et al.
Plos Computational Biology|December 22, 2022
An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumorsXueer Chen, Lujia Chen, Cornelius H L Kürten, et al.
ERJ Open Research|January 15, 2025
Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertensionAnna Kirillova, Meena Sethuraman, Xishuang Dong, et al.
Arthritis Care & Research|August 7, 2025
LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung DiseaseCristina M Padilla, Robert Lafyatis, Kevin F Gibson, et al.
The European Respiratory Journal|June 22, 2019
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosisChristina Morse, Tracy Tabib, John Sembrat, et al.
Arthritis Research & Therapy|January 24, 2016
Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosisMichael E Johnson, Andrew V Grassetti, Jaclyn N Taroni, et al.
Human Immunology|November 27, 2008
The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patientsTimothy R D J Radstake, Madelon C Vonk, Marieke Dekkers, et al.
Nature Communications|June 4, 2016
Tenascin-C drives persistence of organ fibrosisSwati Bhattacharyya, Wenxia Wang, Luisa Morales-Nebreda, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysisSébastien Sanges, Lisa Rice, Ly Tu, et al.
Journal of Scleroderma and Related Disorders|January 10, 2022
A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic SclerosisKristi Kong, Diane Koontz, Christina Morse, et al.
Pageof 26